Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich M Zanger

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Frontiers in Pharmacology|August 20, 2011
Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone HydrolysisStephan Riedmaier, Kathrin Klein, Stefan Winter, et al.
ALTEX|August 30, 2003
V79 Chinese hamster cells genetically engineered for polymorphic cytochrome P450 2D6 and their predictive value for humansNiels Krebsfaenger, Thomas E Mürdter, Ulrich M Zanger, et al.
Pharmacogenetics and Genomics|September 27, 2006
A silent mutation (2939G>A, exon 6; CYP2D6*59) leading to impaired expression and function of CYP2D6Claudia Toscano, Sebastian Raimundo, Kathrin Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4alpha: evidence for direct regulation in the intestineHeike Tegude, Anke Schnabel, Ulrich M Zanger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2009
A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomesMiia Turpeinen, Ute Hofmann, Kathrin Klein, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 12, 2014
Targeting nuclear receptors with lentivirus-delivered small RNAs in primary human hepatocytesMaria Thomas, Jessica K Rieger, Benjamin A Kandel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 7, 2014
A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cellsMarcus Klein, Maria Thomas, Ute Hofmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 3, 2004
Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosteroneLandry K Kamdem, Ingolf Meineke, Ina Koch, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemiaRyoichi Fujiwara, Mathias Haag, Elke Schaeffeler, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 21, 2018
The azole fungicide tebuconazole affects human CYP1A1 and CYP1A2 expression by an aryl hydrocarbon receptor-dependent pathwayConstanze Knebel, Tanja Heise, Ulrich M Zanger, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Frontiers in Pharmacology|August 20, 2011
Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone HydrolysisStephan Riedmaier, Kathrin Klein, Stefan Winter, et al.
ALTEX|August 30, 2003
V79 Chinese hamster cells genetically engineered for polymorphic cytochrome P450 2D6 and their predictive value for humansNiels Krebsfaenger, Thomas E Mürdter, Ulrich M Zanger, et al.
Pharmacogenetics and Genomics|September 27, 2006
A silent mutation (2939G>A, exon 6; CYP2D6*59) leading to impaired expression and function of CYP2D6Claudia Toscano, Sebastian Raimundo, Kathrin Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4alpha: evidence for direct regulation in the intestineHeike Tegude, Anke Schnabel, Ulrich M Zanger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2009
A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomesMiia Turpeinen, Ute Hofmann, Kathrin Klein, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 12, 2014
Targeting nuclear receptors with lentivirus-delivered small RNAs in primary human hepatocytesMaria Thomas, Jessica K Rieger, Benjamin A Kandel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 7, 2014
A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cellsMarcus Klein, Maria Thomas, Ute Hofmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 3, 2004
Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosteroneLandry K Kamdem, Ingolf Meineke, Ina Koch, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemiaRyoichi Fujiwara, Mathias Haag, Elke Schaeffeler, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 21, 2018
The azole fungicide tebuconazole affects human CYP1A1 and CYP1A2 expression by an aryl hydrocarbon receptor-dependent pathwayConstanze Knebel, Tanja Heise, Ulrich M Zanger, et al.
Pageof 14